e-learning
resources
Virtual 2021
05.09.2021
Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Update on lung cancer screening with low-dose CT
R. Meza (Ann Arbor, United States of America)
Source:
Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening
Session:
Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening
Session type:
Journal session
Number:
1354
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Meza (Ann Arbor, United States of America). Update on lung cancer screening with low-dose CT. Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Screening for lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=71
Year: 2001
Cost-effectiveness of lung cancer screening with CT-scan
Source: Virtual Congress 2020 – Frontiers of lung cancer screening
Year: 2020
The evidence on CT: lung cancer screening
Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice
Year: 2018
Prevalence of COPD in a lung cancer screening programme with low dose CT scan
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009
Factors determining early adherence to a lung cancer screening protocol
Source: Eur Respir J 2007; 30: 532-537
Year: 2007
Low-dose chest computed tomographic screening and invasive diagnosis of pulmonary nodules for lung cancer in never-smokers
Source: Eur Respir J, 56 (5) 2000177; 10.1183/13993003.00177-2020
Year: 2020
Towards personalized lung cancer CT screening in Europe
Source: Virtual Congress 2020 – Screening and imaging in lung cancer
Year: 2020
Missed lung cancer on chest radiography – does it affect the outcome?
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007
Introduction on the ESR/ERS statement on low-dose lung cancer screening
Source: International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?
Year: 2019
An update on computed tomography screening for lung cancer
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=195
Year: 2004
Role of CT guided lung biopsy in the diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 65s
Year: 2001
Screening of lung cancer: imaging modalities
Source: Annual Congress 2009 - PG2 Core Curriculum Postgraduate Course: Lung cancer imaging: case and problem based
Year: 2009
Prevalence of interstitial lung disease (ILD) in a lung cancer screening program using low-dose computer tomography (CT)
Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease
Year: 2011
Computed tomographic screening for lung cancer: individualising the benefit of the screening
Source: Eur Respir J 2007; 30: 843-847
Year: 2007
Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes
Source: Eur Respir J 2010; 35: 146-151
Year: 2010
Interstitial lung diseases in a lung cancer screening trial
Source: Eur Respir J 2011; 38: 392-400
Year: 2011
Study to assess the utility of head CT in the staging of lung cancer in the post-PET era
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009
PET/CT of lung cancer
Source: International Congress 2018 – PG4 Imaging of the chest
Year: 2018
Impact of PET scan on staging and management of lung cancer patients in Indian scenario
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Lung cancer screening by low-dose spiral computed tomography
Source: Eur Respir J 2001; 18: 857-866
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept